Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Barry Kapik"'
Autor:
Barry Kapik, Debra A. Goldstein, Quan Dong Nguyen, Rahul N. Khurana, Mark R. Barakat, Thomas A. Ciulla, Thomas A. Albini, Emmett T. Cunningham, Dilraj S. Grewal
Publikováno v:
American Journal of Ophthalmology. 237:310-324
PURPOSE To assess the relationship between best corrected visual acuity (BCVA) and central subfield optical coherence tomography (OCT) features in noninfectious uveitis (NIU)-related macular edema (ME). DESIGN Clinical cohort study from post hoc anal
Autor:
Steven Yeh, Pauline T. Merrill, Barry Kapik, Michael A Singer, Thomas A. Ciulla, Colette Hall
Publikováno v:
Clinical & Experimental Ophthalmology. 50:23-30
Background This post hoc analysis compared the efficacy and safety of CLS-TA to other commonly available treatments for noninfectious uveitis (NIU). Methods Results from the PEACHTREE study were compared between subjects randomized to CLS-TA not requ
Publikováno v:
Ophthalmol Retina
PURPOSE: To assess the relationship between best-corrected visual acuity (BCVA) and anatomic features in patients with macular edema (ME) related to retinal vein occlusion (RVO). DESIGN: Post hoc analysis of 3 clinical trials, which included verified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce3e30e6715b729ff0c01f341830eee
https://europepmc.org/articles/PMC9927025/
https://europepmc.org/articles/PMC9927025/
Publikováno v:
Ophthalmology. Retina. 5(7)
This study assessed relationships between best-corrected visual acuity (BCVA), central subfield thickness (CST), and ellipsoid zone (EZ) integrity in macular edema (ME) patients.Post hoc analysis of 6 clinical trials, which included verified diagnose
Autor:
Thomas A. Ciulla, Eric B. Suhler, Milan Shah, Mark R Barakat, Pauline T. Merrill, Christopher R. Henry, Robert C Wang, Barry Kapik, Eduardo Uchiyama, Steven Yeh, Rahul N. Khurana
Publikováno v:
British Journal of Ophthalmology. :bjophthalmol-2020
PurposeTo assess the extended efficacy and safety of suprachoroidal triamcinolone acetonide injectable suspension (CLS-TA) among patients with macular oedema (ME) secondary to non-infectious uveitis (NIU).MethodsPatients with uveitic ME were treated
Autor:
Kane Frances Elizabeth, Elias Reichel, Ken Green, David M. Brown, Sanford Chen, José M. Ruiz-Moreno, David S. Boyer, Peter A. Campochiaro, Clare Bailey, Andrew Pearson, Bruce R. Garretson, Kathleen Billman, Seenu M. Hariprasad, Gisèle Soubrane, Barry Kapik, Amod Gupta
Publikováno v:
Ophthalmology. 119(10)
Objective To assess long-term efficacy and safety of intravitreal inserts releasing 0.2 μg/d (low dose) or 0.5 μg/d (high dose) fluocinolone acetonide (FAc) in patients with diabetic macular edema (DME). Design Two randomized, sham injection-contro
Autor:
Peter A, Campochiaro, Gulnar, Hafiz, Syed Mahmood, Shah, Steven, Bloom, David M, Brown, Miguel, Busquets, Thomas, Ciulla, Leonard, Feiner, Nelson, Sabates, Kathleen, Billman, Barry, Kapik, Ken, Green, Frances, Kane, James, Hays
Publikováno v:
Ophthalmology. 117(7)
Purpose To compare Iluvien intravitreal inserts that release 0.2 or 0.5 μg/day of fluocinolone acetonide (FA) in patients with diabetic macular edema (DME). Design Prospective, randomized, interventional, multicenter clinical trial. Participants We
Autor:
L. Duarte, Andrew Pearson, John R. Gonder, Kathleen Billman, Kane Frances Elizabeth, David S. Boyer, Steven A. Madreperla, Frank G. Holz, Barry Kapik, Peter A. Campochiaro, Michael J. Tolentino, Amod Gupta, Thomas A. Ciulla, David M. Brown
Publikováno v:
Ophthalmology. 118:626-635.e2
Objective To assess the efficacy and safety of intravitreal inserts releasing 0.2 μg/day (low dose) or 0.5 μg/day (high dose) fluocinolone acetonide (FA) in patients with diabetic macular edema (DME). Design Two parallel, prospective, randomized, s